of the types of protocols used for ADHD, PTSD, depression, and TBI remediation with SUD subjects comorbid for those conditions need to be reported.Open clinical trials that assess the efficacy of EEG biofeedback in addressing the specific qEEG changes of chronic alcohol, heroin, cannabis and stimulant abuse need to be reported.The physiological and psychological processes of the therapeutic effects of EEG biofeedback, including studies of qEEG and ERP changes, need to be investigated and reported.Studies need to adhere to clearly defined outcome measures that have established reliability and validity.
